84 results
8-K
EX-99.1
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
, an age-related decline in physical function which leads to greater risk of hospitalization, disability, and death.
About MyMD Pharmaceuticals, Inc
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal. Directors need not be stockholders unless … . A vacancy in any office because of death, resignation, removal, disqualification or any other cause shall be filled in the manner prescribed
8-K
EX-2.1
TNFA
TNF Pharmaceuticals Inc.
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
, until their successors have been duly elected or appointed and qualified or until their earlier death, resignation or removal.
Directors … , until their successors have been duly elected or appointed and qualified or until their earlier death, resignation or removal.
Stock and Stock
8-K
EX-99.1
06w196 txm
4 Oct 23
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023
4:30pm
8-K
EX-99.1
9v02v9hc7a7
14 Aug 23
Regulation FD Disclosure
8:30am
8-K
EX-99.1
gmzthuv9bk6msdb9yc
3 Aug 23
MyMD Pharmaceuticals Phase 2 Trial Update
4:30pm
8-K
EX-99.1
vw1qt6c tx5
31 Jul 23
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline
9:00am
8-K
EX-99.1
8hmcrxvgi1hzriu5fmq
3 Aug 22
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
igx6m eyq83
26 Jul 22
Regulation FD Disclosure
4:30pm